Ricardo Sánchez-Prieto

9PUBLICATIONS
38CO-AUTHORS
Molecular targetsChemotherapyRadiation therapyAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 03, 2024
The CDK12-BRCA1 signaling axis mediates dinaciclib-associated radiosensitivity through p53-mediated cellular senescence.

Natalia García Flores, Diego M Fernández-Aroca, Cristina Garnés-García

|Jul 17, 2023
Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.

Borja Diaz de Greñu, Diego M Fernández-Aroca, Juan A Organero

|May 07, 2023
LDR brachytherapy offers superior tumor control to single-fraction HDR prostate brachytherapy: A prospective study.

Isabel E Jimenez-Garcia, Sebastia Sabater, Rocio Martinez-Gutierrez

|Feb 11, 2023
P38 MAPK and Radiotherapy: Foes or Friends?

Natalia García-Flores, Jaime Jiménez-Suárez, Cristina Garnés-García

|Jul 27, 2022
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.

Elena Arconada-Luque, Jaime Jiménez-Suarez, Raquel Pascual-Serra

|Oct 16, 2021
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.

Marta Ortega-Muelas, Olga Roche, Diego M Fernández-Aroca

Pageof 2